Guyueqing

Dr. Gu Yueqing, the founding Dean of the School of Engineering at China Pharmaceutical University, is a professor and doctoral supervisor in the field of biomedical engineering. She holds the esteemed position of discipline leader and enjoys the special allowance granted by The State Council. Additionally, she is recognized as a first-level training object under Jiangsu Province's 333 project and serves as a young and middle-aged academic leader in Jiangsu Province's Blue Project. She has pioneered the establishment of a molecular imaging drug research platform, developed an in vivo visualization technology system for drug development and efficacy evaluation, and created various contrast agents and in vitro diagnostic kits for tumor diagnosis.

[1] Zhou Li, Yu Bin, Gao Mengqiu, Chen Rui, Li Zhiyu, Gu Yueqing*, Bian Jinlei*, Ma Yi*. DNA framework-engineered chimeras platform enables selectively targeted protein degradation[J]. Nature Communications, 2023, 14(1): 4510.

[2] Li Changsheng, Lin Qiao, Hu Fangrong, Bao Ruichu, Cai Huiming, Gu Yueqing*. Based on lapatinib innovative near-infrared fluorescent probes targeting HER1/HER2 for in vivo tumors imaging[J]. Biosensors and Bioelectronics, 2022, 214: 114503.

[3] Zhai Yuewen, He Xiaorong, Li Ying, Han Ran, Ma Yuying, Gao Peng, Qian Zhiyu, Gu Yueqing*, Li Siwen*. A splenic-targeted versatile antigen courier: iPSC wrapped in coalescent erythrocyte-liposome as tumor nanovaccine[J]. Science Advances, 2021, 7(35): eabi6326.

[4] Ma Yi, Ma Yuxuan, Gao Mengqiu, Han Zhihao, Jiang Wen, Gu Yueqing*, Liu Yi*. Platelet‐Mimicking Therapeutic System for Noninvasive Mitigation of the Progression of Atherosclerotic Plaques[J]. Advanced Science, 2021, 8(8): 2004128.

[5] Zhaohui Wang, Yi Ma, Xiyuan Yu, Qi Niu, Zhihao Han, Han Wang, Tingting Li, Dingping Fu, Samuel Achilefu, Zhiyu Qian, Yueqing Gu*. Targeting CXCR4–CXCL12 axis for visualizing, predicting, and inhibiting breast cancer metastasis with theranostic AMD3100–Ag2S quantum dot probe[J]. Advanced Functional Materials, 2018, 28(23): 1800732. 

the National Natural Science Foundation of China：Study of a functional molecules-mediated instant efficacy evaluation system for the anti-hepatoma drugs (NSFC82230070)； National Key Research and development Program: Establishment of AI model for in vivo staging colorectal cancer and study on its molecular mechanism (2022YFE0138800); Natural Science Foundation of Jiangsu Province: (BE2023842)

In 2017, the Ministry of Education's Scientific Research Outstanding Achievement Award (Natural Science Award);

In 2021, second Prize of Science and Technology of Jiangsu Province 

Biomedical Engineering Technology; Design principle and preparation of diagnostic reagents